Clinical and Functional Outcome of the MobileLink Acetabular Cup System in the Short-, Mid-, and Longterm Follow-up
NCT ID: NCT04688593
Last Updated: 2024-01-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
520 participants
OBSERVATIONAL
2021-05-04
2036-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The MobileLink hip prosthesis system is a CE marked medical device. This means the the safety and performance of the prosthesis ist approved. Aim of the study is to collect clinical data about the outcome of the MobileLink hip prosthesis system under routine condition and to determine the satisfaction of the patients.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Investigation Comparing Two Different Ultra-porous Coated Surfaces of Uncemented Cups
NCT05773261
Prospective Clinical 5-year Follow-up of the LINK® SP-CL® Hip Prosthesis Stem
NCT02288117
Prospective Randomised Study of a New an Uncemented Stem.
NCT04599582
Benefit of Orthopedic Navigation in the ARThroplasty of the Hip
NCT01496300
Post Market, Retrospective Study to Evaluate Patients Implanted With Medacta Versafit Cup DM ™️ 2 Years Post-op
NCT03897387
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MobileLink
Patients who receive a MobileLink hip prosthesis system will be followed-up for 10 years.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ≥ 18 years
* Fully signed patient informed cons
Exclusion Criteria
* Body Mass Index (BMI) ≥ 40 kg/m²
* Patient who is foreseeable not able to understand the study and the study-related circumstances
* Patients who is foreseeable non-compliant to the treatment and the follow-ups
* Pregnant or breast-feeding women
* Prisoner
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Waldemar Link GmbH & Co. KG
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Lubinus Stiftung
Kiel, , Germany
NHS FIFE Victoria Hospital
Kirkcaldy, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Jörg Löwe
Role: primary
Muhammad Adeel Akhtar
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HP15
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.